<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940817-2-00275</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=25 g=1 f=1 --> Slikker W Jr, Gaylor DW. Biologically based dose-response model for neurotoxicity risk assessment. Korean J Toxicol 1990; 6:204&hyph;213. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Slikker W Jr, Holson RR, Ali SF, Kolta MG, Paule MG, Scallet AC, McMillan DE, Bailey JR, Hong JS, Scalzo FM. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Neurotoxicology 1989; 10:529&hyph;542. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Smith MA, Grant LD, Sors AI, eds. Lead Exposure and Child Development: An International Assessment. Dordrecht, Netherlands: Kluwer Academic Publishers, 1989. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Solomon PR, Pendlebury WW. A model systems approach to age-related memory disorders. Neurotoxicology 1988; 9:443&hyph;462. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins Co, 1980. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Roy DN, Robertson RC. Guam amyotrophic lateral sclerosis-Parkinsonism-dementia linked to a plant excitant neurotoxin. Science 1987; 237:517&hyph;522. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Squibb, RE, Tilson, HA, Meyer, OA, Lamartiniere, CA. Neonatal exposure to monosodium glutamate alter the neurobehavioral performance of adult rats. Neurotoxicology, 1991; 2:471&hyph;484. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Stanton ME, Spear LP. Comparability of endpoints across species in developmental neurotoxicity. Neurotoxicol Teratol 1990; 12:261&hyph;268. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Stebbins WC, Coombs C. Behavioral assessment of ototoxicity in nonhuman primates. In: Weiss B, Laties VG, eds. Behavioral Toxicology. New York: Plenum Press, 1975. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Sterman AB, Schaumburg HH. Neurotoxicity of selected drugs. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:593&hyph;612. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Stewart RD, Fisher TN, Hosko R. Experimental human exposure to methylene chloride. Arch Environ Health 1972; 25:342&hyph;348. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Strong MJ, Garruto RM. Potentiation in the neurotoxic induction of experimental chronic neurodegenerative disorders: n-butyl benzenesulfonamide and aluminum chloride. Neurotoxicology 1991; 12:415&hyph;426. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Suzuki K. Special vulnerabilities of the developing nervous system to toxic substances. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:48&hyph;61. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Terrace HS. Errorless discrimination learning in the pigeon: Effects of chlorpromazine and imipramine. Science 1963; 140:318&hyph;319. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Thompson FN Jr, Porter JK. Tall fescue toxicosis in cattle: could there be a public health problem. Vet Human Toxicol 1990; 32:51&hyph;57. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Tilson HA, Cabe PA. Strategy for the assessment of neurobehavioral consequences of environmental factors. Environ Health Perspect 1978; 26:287&hyph;299. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Tilson HA. Practical considerations in establishing valid and sensitive neurobehavioral test methods. Zbl Bakt Hyg B 1987; 185:10&hyph;15. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Tilson HA. Screening for neurotoxicity: principles and practices. J Am Coll Toxicol 1989; 8:13&hyph;17. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Tilson HA. Behavioral indices of neurotoxicity. Toxicologic Pathology 1990a; 18:96&hyph;104. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Tilson HA. Neurotoxicology in the 1990s. Neurotoxicol Teratol 1990b; 12:293&hyph;300. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Tilson HA, Mitchell CL. Neurotoxicants and adaptive responses of the nervous system. Fed Proc 1983; 42:3189&hyph;3190. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Tilson HA, Mitchell CL. Neurobehavioral techniques to assess the effects of chemicals on the nervous system. Ann Rev Pharmacol Toxicol 1984; 24:25&hyph;50. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Tilson HA, Moser VC. Comparison of screening approaches. Neurotoxicology 1992; 13:1&hyph;14. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> United States Environmental Protection Agency (U.S. EPA). Neurotoxicity Testing Guidelines. Springfield, VA: National Technical Information Service, 1991. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Valciukas JA. Foundations of Environmental and Occupational Neurotoxicology. New York: Van Nostrand Reinhold, 1991. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Veronesi B. The use of cell culture for evaluating neurotoxicity. In: Tilson HA, Mitchell CL, eds. New York: Raven Press, 1991:21&hyph;50. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Veronesi B, Jones K, Pope C. The neurotoxicity of subchronic acetylcholinesterase (AChE) inhibition in rat hippocampus. Toxicol Appl Pharmacol 1990; 104:440&hyph;456. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Verity MA, Sarafian TS, Guerra W, Ettinger A, Sharp J. Ionic modulation of triethyllead neurotoxicity in cerebellar granule cell culture. Neurotoxicology 1990; 11:415&hyph;426. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Vorhees CV. Reliability, sensitivity and validity of indices of neurotoxicity. Neurotoxicol Teratol 1987; 9:445&hyph;464. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Waddell, WJ. The science of toxicology and its relevance to MC5. Reg. Toxicol. Pharmacol. 1993; 18:13&hyph;22. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Walker CH, Faustman WO, Fowler SC, Kazar DB. A multivariate analysis of some operant variables used in behavioral pharmacology. Psychopharmacology 1981; 74:182&hyph;186. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Weiss B. Risk assessment: The insidious nature of neurotoxicity and the aging basis. Neurotoxicology 1990; 11:305&hyph;313. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Williamson AM. The influence of subject characteristics on the identification of acute effects of solvent exposure. Arbete och Halsa 1991; 35:14&hyph;18. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Willis WD Jr, Grossman RG. Neurotransmission. In: Medical Neurobiology. St. Louis: C.V. Mosby, 1973:457. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> World Health Organization (WHO). Principles and Methods for the Assessment of Neurotoxicity Associated with Exposure to Chemicals. Environmental Health Criteria Document 60. Geneva: World Health Organization, 1986. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Wyllie TD, Morehouse LC. Mycotoxic Fungi, Mycotoxins, Mycotoxicoses, An Encyclopedic Handbook. New York: Marcel Dekker, Inc., 1978, Vols. 1&hyph;3. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Wyzga R. Towards quantitative risk assessment for neurotoxicity. Neurotoxicology 1990; 11:199&hyph;208. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Yokel RA. Repeated systemic aluminum exposure effects on classical conditioning of the rabbit. Neurobehav Toxicol Teratol 1983; 5:41&hyph;46. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Yokel RA, Provan SD, Meyer JJ, Campbell SR. Aluminum intoxication and the victim of Alzheimer's disease: similarities and differences. Neurotoxicology 1988; 9:429&hyph;442. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Zenick H. Use of pharmacological challenge to disclose neurobehavioral deficits. Fed Proc 1983; 42:3191&hyph;3195 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=71 g=1 f=1 --> Prepared by <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=25 g=1 f=1 --> Working Party on Neurotoxicology <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Subcommittee on Risk Assessment <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Federal Coordinating Council on Science, Engineering, and Technology <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=25 g=1 f=1 --> Lawrence W. Reiter, USEPA, Chair <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Hugh A. Tilson, USEPA, Executive Secretary <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> John Dougherty, NIOSH <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> G. Jean Harry, NIEHS <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Carol J. Jones, OSHA <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Suzanne McMaster, USEPA <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> William Slikker, NCTR/FDA <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Thomas J. Sobotka, FDA <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            